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Abstract: There are continued concerns about endocrine-disrupting chemical effects, and appropriate vertebrate models for assess-
ment of risk are a high priority. Frog tadpoles are very sensitive to environmental substances because of their habitat and the complex 
processes of metamorphosis regulated by the endocrine system, mainly thyroid hormones. During metamorphosis, marked alteration 
in hormonal factors occurs, as well as dramatic structural and functional changes in larval tissues. There are a variety of mechanisms 
determining thyroid hormone balance or disruption directly or indirectly. Direct-acting agents can cause changes in thyroxine synthe-
sis and/or secretion in thyroid through effects on peroxidases, thyroidal iodide uptake, deiodinase, and proteolysis. At the same time, 
indirect action may result from biochemical processes such as sulfation, deiodination and glucuronidation. Because their potential to 
disrupt thyroid hormones has been identified as an important consideration for the regulation of chemicals, the OECD and the EPA 
have each established guidelines that make use of larval African clawed frogs (Xenopus laevis) and frog metamorphosis for screening 
and testing of potential endocrine disrupters. The guidelines are based on evaluation of alteration in the hypothalamic-pituitary-thyroid 
axis. One of the primary endpoints is thyroid gland histopathology. Others are mortality, developmental stage, hind limb length, snout-
vent length and wet body weight. Regarding histopathological features, the guidelines include core criteria and additional qualitative 
parameters along with grading. Taking into account the difficulties in evaluating amphibian thyroid glands, which change continuously 
throughout metamorphosis, histopathological examination has been shown to be a very sensitive approach. (DOI: 10.1293/tox.25.1; J 
Toxicol Pathol 2012; 25: 1–9)
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Introduction
There are many concerns about endocrine-disrupting 
chemical effects on wild animals as well as humans. Con-
siderable numbers of chemicals have been shown to alter the 
thyroid system in vertebrates, and disruption of the thyroid 
axis has been identified as an important consideration for 
the regulation of chemicals. Thus, focusing on thyroid toxic-
ity, the OECD and EPA established guidelines for investiga-
tion of frog metamorphosis1,2. Because amphibian tadpoles 
have a thin, permeable skin and inhabit aquatic environ-
ments, they are exposed to toxicants through both dermal 
and dietary routes and appear to be particularly susceptible 
to a number of contaminants in wastewater discharged from 
agricultural fields and from industrial and household areas. 
In addition, the fact that frog metamorphosis is regulated 
by thyroid hormones (THs), promoting the remodeling of 
the aquatic larvae into an adult tetrapod, means that the 
dramatic structural and functional changes of larval tissues 
can be readily applied as parameters reflecting endocrine 
disruption.
The frog thyroid glands, located between the eyes (Fig. 
1), show various morphological changes during metamor-
phosis and under conditions of exposure to certain com-
pounds. Here, the regulation by THs, focusing on affecting 
factors in addition to the metamorphosis assay, is reviewed.
Thyroid Hormones and Their Related Effectors
The thyroid gland secretes thyroxine (T4), which is 
converted to a more biologically active form, 3,3′,5-triio-
dothyronine (T3), mainly in the peripheral target tissues. 
Transport of THs in the blood is accomplished through 
binding to transport proteins, predominantly transthyretin 
(TTR), with conjugation and degradation processes oc-
curring in the liver and subsequent secretion in bile. Some 
THs are coupled with bacterial deconjugation and undergo 
reabsorption in the intestine. TH structures are conserved 
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between vertebrates, and their production and secretion are 
essentially the same in amphibians and mammals.
There are several processes that influence the thyroid 
hormone balance, such as sulfation, deiodination and gluc-
uronidation (see Fig. 2). Both inhibition of thyroidal iodide 
uptake and suppression of thyroidal peroxidase activity can 
disrupt TH synthesis and secretion. In addition, inhibition 
of 5-deiodinase in the peripheral tissue is related to reduc-
tion of conversion from T4 to T3, while induction of hepatic 
microsomal enzymes such as phenol sulfotransferase and 
UDP-glucuronyl transferase leads to increase in excretion 
of both T4 and T3 into bile. Furthermore, competitive bind-
ing to thyroid transport proteins results in reduced levels 
of total and free THs in serum. Therefore, there are many 
potential targets of environmental contaminants that could 
be involved in disruption of TH metabolism.
Rahman and Yamauchi found TH sulfating activity to 
be present in the liver cytosol in frog tadpoles and that the 
T3:T4 sulfating activity ratio varies during developmental 
stages3, sulfation being inhibited by chemical compounds 
such as halogenated phenol and phenolic compounds, p-ni-
trophenol, dopamine, 17beta-estradiol (E2) and dihydroxye-
piandrosterone. Compared with sulfation, glucuronidation 
has been poorly studied in amphibians, in line with its char-
acter as a relatively minor pathway. However, a subset of the 
responsible enzymes, glucuronidases (UGTs), can reduce 
circulating levels of THs through biliary elimination as in 
mammals. Regarding phase I species, hepatic microsomal 
cytochrome P450 2B1 was found to be induced by pento-
barbital in adults of the semiaquatic frog, Rana pipiens, but 
not in frog tadpoles and adults of the aquatic frog Xenopus 
laevis4. Deiodinase enzymes, type 2 and 3 iodothyronine 
deiodinase, are found in several peripheral target tissues in 
amphibians, and the level of expression is closely connected 
with metamorphosis5,6.
The most characteristic feature of TTR from nonmam-
malian vertebrates, such as amphibians, is their higher af-
finity for T3 than for T43,7. Binding of chemicals to TTR 
decreases their effective free concentrations in plasma and 
changes the apparent affinity for THs, which can diminish 
cellular uptake and biological responses and would alter 
plasma TH homeostasis. Therefore, chemicals interfer-
ing with T3 binding to TTR may directly affect the free 
concentration of plasma T3 and its plasma clearance rate. 
Chemical compounds including diethylstilbestrol (DES)8,9, 
Fig. 1.  Arrows indicate thyroid glands in Stage 51.
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phenolic and phenol compounds10,11 and pentachlorophenol 
and ioxynil8,9 have the potential to bind to TTR, and Yamau-
chi et al. reported that with amphibian TTR, DES possesses 
similar affinity to T3, which is the natural ligand8.
Metamorphosis and Related Hormones
Amphibian metamorphosis is divided roughly into 3 
stages, premetamorphosis, prometamorphosis and climax 
(see Fig. 3). The premetamorphic stage is the period until the 
appearance of the hind limbs, and the prometamorphic pe-
riod is from their appearance to that of the forelimbs. Subse-
quently, during the period of metamorphic climax, resorp-
tion of tail and gills and development of lungs occur. The 
metamorphosis processes are systemically controlled by 
THs12–15. For example, treatment of tadpoles with synthetic 
thyroid hormone receptor antagonists (e.g., NH-3) leads to 
retardation or even complete blockade of Xenopus laevis 
(X. laevis) metamorphic development16. In turn, exposure 
of X. laevis tadpoles to low nanomolar concentrations of T3 
or synthetic thyroid hormone receptor agonists (e.g., GC-1) 
causes precocious induction of metamorphosis17. The sen-
sitivity to TH varies according to the developmental stage, 
and the amount of spontaneously released thyroid stimulat-
ing hormone (TSH) is higher in late prometamorphic and 
climactic tadpoles than in early prometamorphic larvae and 
juvenile and adult frogs18. Low levels of circulating thyro-
globulin are found in tadpoles at the early stages, but ex-
tremely high levels are evident at the metamorphic climax19.
In amphibians, both corticotrophin-releasing hormone 
(CRH) and gonadotropin-releasing hormone (GnRH), in ad-
dition to TRH23, have been considered as candidates for the 
TSH-releasing factor20–22. In the bullfrog, CRH was found 
to be the most potent TSH-releasing substance in both adult 
and larval pituitary cells, while both TRH and GnRH mod-
erately stimulated the release of TSH from the adult pitu-
itary but not larval cells24. Kaneko et al. demonstrated that 
TH suppressed the CRH-induced release of TSH, but not the 
basal release, from larval, juvenile and adult bullfrog pitu-
itaries in vitro18. In addition, Jacobs et al. reported that intra-
venously injected mammalian luteinizing hormone-releas-
ing hormone (LHRH) was able to raise circulating levels 
of T4 as well as testosterone (T) in three frog species, Rana 
ridibunda, Rana temporaria and Rana esculenta21. Regard-
ing prolactin (PRL), inhibitory effects may be exerted on 
metamorphosis, but this is controversial. Huang and Brown 
concluded that PRL does not play a role as a juvenile hor-
mone in X. laevis, but overexpression of PRL does specifi-
cally inhibit some but not all programs of tail resorption25.
Research has indicated concomitant elevation of THs 
and corticoids as metamorphosis progresses26–28. Accord-
ing to Kikuyama et al., the aldosterone plasma level is low 
prior to the onset of climax, but then there is a sharp rise, 
and combined adrenocorticotropin (ACTH) and T treatment 
causes a marked increase in concentration28. Gray and Jans-
sens observed that corticosterone stimulated T3-induced 
metamorphosis in X. laevis tadpoles29.
Steroid sex hormones also serve to modulate thyroid 
system functions. Gray and Janssens observed that testos-
terone and E2 inhibited T3-induced metamorphosis in X. 
laevis tadpoles29, while Hogan et al. demonstrated a delay 
in the time for Rana pipiens tadpoles to undergo metamor-
phosis when exposed to ethinylestradiol during either mid-
metamorphosis or throughout the entire larval period30.
Effects of Chemical Compounds on Amphibian 
Metamorphosis
In the past few decades, several thyroid disrupting 
substances have been tested for toxicity using amphibians. 
Xenopus and other anurans have been generally applied to 
assess the developmental effects of a variety of xenobiotics.
There have been a considerable number of reports re-
garding inhibitors of T4 synthesis that inactivate peroxidas-
es. After exposure to propylthiouracil (PTU), also known to 
inhibit deiodinase, X. tropicalis tadpoles showed no signs 
of decline in body length or body weight but a considerable 
reduction in the developmental stage and hind limb length31. 
Opitz et al. reported effects of exposure to PTU and an-
other peroxidase inhibitor ethylenthiourea (ETU), in X. 
laevis32,33. Metamorphic retardation caused by ETU was as-
sociated with concentration-dependent histological changes 
in the thyroid gland and increased mRNA expression of 
TSH-beta in the pituitary33. Degitz et al. exposed pre- and 
pro-metamorphic larvae to methimazole, PTU and T434 and 
induced changes in a concentration-dependent manner. Me-
thimazole and PTU caused a delay in larval development 
and morphological changes in the thyroid gland, which were 
characterized as reduced colloid, glandular hypertrophy and 
cellular hyperplasia and hypertrophy. On the other hand, T4 
treatment resulted in a concentration-dependent increase in 
Fig. 3.  The stage of metamorphosis is divided into 3 stages. The pre-
metamorphic stage is the period until the appearance of the 
hind limbs, and the prometamorphic period is from their ap-
pearance to that of the forelimbs. During the period of meta-
morphic climax, resorption of the tail and gills and develop-
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the developmental rate34.
One other potent inhibitor of T4 synthesis, perchlorate, 
disturbs iodide uptake by the follicular cells of the thyroid 
gland. Ammonium perchlorate was found to inhibit fore-
limb emergence, hindlimb development and tail resorption, 
linked to significant hypertrophy of the thyroid follicular 
epithelium at concentrations below those reported in con-
taminated surface waters35,36. Tietge et al. showed that sodi-
um perchlorate inhibits TH synthesis via effects on the sodi-
um-iodide symporter, resulting in retarded metamorphosis 
and histological effects on thyroid as the most sensitive end-
point37. Hu et al. reported the results of thyroid immuno-
histochemistry for T4 in X. laevis exposed to perchlorate38; 
T4 immunoreactivity was concentrated in a ring of colloid 
adjacent to follicle cells, independent of the developmental 
stage. Theirs is the only report regarding this point of view, 
but they suggested the utility of this immunohistochemical 
biomarker, because the intensity of the colloidal T4 ring is 
more sensitive than any other morphological changes (such 
as hind limb length, forelimb emergence, tail resorption, 
thyrocyte hypertrophy or colloid depletion).
There are limited reports concerning environmental 
contaminant chemicals. Gutleb et al. found that time un-
til metamorphic transformation was prolonged, the body 
weights of froglets were increased after exposure to poly-
chlorinated biphenyls (PCB) and T4 levels were lowered, 
although not significantly39. Iwamuro et al. established that 
bisphenol A (BPA) induced deceleration of both spontane-
ous and T4-induced metamorphic changes, with suppression 
of thyroid hormone receptor (TR) beta gene expression40. 
Polybrominated diphenyl ether (BDE-47) and a commercial 
pentabromodiphenyl ether mixture (DE-71) caused delay in 
tail regression in X. laevis41. According to Carlsson et al., 
autoradiograms revealed high concentrations and long-term 
retention of 2,2’,4,4’,5-pentabromodiphenyl ether (BDE-99) 
in adipose tissue and melanin in frogs exposed as both tad-
poles and juveniles, with lower developmental stages sug-
gesting possible thyroid hormone disruption42. Fort et al. re-
corded delayed metamorphosis and enlarged thyroid glands 
with follicular hyperplasia in X. tropicalis and X. Laevis 
tadpoles exposed to the insecticide methoxychlor43,44.
Regarding actual environmental contamination, Sow-
ers et al. reported that municipal wastewater effluent con-
taining measurable amounts of a variety of pharmaceuticals, 
personal care products, industrial compounds and natural 
and synthetic hormones could alter the timing of the meta-
morphic process in frogs45. In their latest report of a field 
study of the native Wood Frog in the Athabasca Oil Sands 
region of northern Alberta, Canada, metamorphosis was de-
layed or not complete at the end of the 75 day study period46.
There is not only evidence of inhibitory effects of com-
pounds. Cheek et al. showed that the herbicide acetochlor 
accelerated forelimb emergence and the beginning of meta-
morphic climax, apparently by interacting with T3, but also 
possibly by weakly opposing the inhibitory actions of cor-
ticosterone on development of premetamorphic tadpoles47.
The doses used in most of these studies were greater 
than the levels to which anurans are exposed in the natural 
environment, so further investigations are required to de-
termine whether exposure to chemicals at environmentally 
relevant concentrations can affect frog metamorphosis.
In contrast to the data showing a clear effect on meta-
morphosis of chemical compounds, some negative data 
have been reported. UV filters such as 4-methylbenzylidene 
camphor (4-MBC) and 3-benzylidene camphor (3-BC) have 
been found to not affect the thyroid system and the rate of 
metamorphosis at environmental concentrations, and thus, 
they seem not to exhibit thyroid-mimicking or antithyroid 
activity48. Carr et al. reported exposure to one herbicide, at-
razine, did not exert any effects on metamorphosis49.
There are several reports concerning effects on am-
phibian larvae of triclosan, which is a bacteriocide used 
in personal care and consumer products such as shampoo, 
soaps, deodorants, toothpaste and plastic ware, and so on. 
The release of triclosan into the environment is of particu-
lar concern as it is structurally similar to TH. Veldhoen et 
al. reported that triclosan was found to affect hind limb de-
velopment in amphibians50. And then Fort et al. conducted 
a GLP study in compliance with the guidelines mentioned 
below, and indicated that environmentally relevant concen-
trations do not alter the normal course of thyroid-mediated 
metamorphosis in this standard anuran model51. The effect 
of triclosan has been controversial52–56.
Guideline Establishment
The amphibian hypothalamic-pituitary-thyroid (HPT) 
axis controls TH levels in the same way as it does in mam-
mals, although CRH also plays a role. Therefore, the am-
phibian metamorphosis assay (AMA) represents a general-
ized vertebrate model to the extent that it is based on the 
functions of the HPT axis.
On September 7, 2009, the Organization for Economic 
Co-operation and Development (OECD) adopted the AMA 
using X. laevis as a guideline for testing of chemicals1. The 
US Environmental Protection Agency (EPA) Office of Pre-
vention, Pesticides, and Toxic Substances (OPPTS) also in-
cludes the AMA for detection of thyroid-active chemicals 
in Tier 1 testing of their endocrine screening program. The 
EPA developed the OECD test guidelines through a process 
of harmonization in October 20092. Previously, in 1998, the 
OECD initiated a high-priority activity to revise existing 
guidelines and develop new guidelines for the screening and 
testing of potential endocrine disrupters. One element was 
a test guideline for the screening of substances active on the 
thyroid system of vertebrate species. The 1st OECT Expert 
Consultation on Endocrine Disrupter Testing in Amphib-
ians was held in 2001. Subsequently, the AMA underwent 
extensive validation programs consisting of 3 phases, which 
included intra- and interlaboratory studies demonstrating 
the relevance and reliability of the assay. Mainly the U.S., 
Germany and Japan took part in these trials.
For validation phase 1, T4 and PTU were chosen as 
test chemicals57. The primary objective was a comparative Miyata, Ose 5
evaluation of the utility and sensitivity of two proposed ex-
posure scenarios for detection of stimulating and inhibiting 
effects of thyroid system-disrupting substances.
Phase 2 was interlaboratory multichemical testing with 
a harmonized protocol58. The United Kingdom and Switzer-
land also participated in this phase in addition to Germany, 
Japan and the United States. Three model substances repre-
senting different modes of action on the thyroid system were 
used: sodium perchlorate, T4 and iopanoic acid (IOP). IOP 
is an inhibitor of iodothyronine deiodinases.
Phase 3 studies were conducted to assess the utility of 
the AMA protocol to detect weakly active thyroid system-
disrupting substances and to distinguish thyroid system-
related changes from activity resulting from mechanisms 
not directly related to thyroid system function59. Benzophe-
none-2 (BP-2) and E2 were selected as weakly active and 
non- or indirectly related substances. As a result, the ef-
fect of a weakly antithyroid substance, BP-2, was detected, 
while the endpoints with exposure to E2 did not indicate any 
effect on the thyroid system. Subsequently, validation of the 
assay was subjected to peer review by a panel of indepen-
dent experts.
The procedure in the guidelines is shown simply in 
Table 1 and Table 2. Exposure should be initiated at devel-
opmental stage 51, according to Nieuwkoop and Faber60. 
Hind limb development is used qualitatively for determina-
tion of the developmental stage. The exposure duration is 21 
days. The primary endpoints and observation time points 
are mortality daily, developmental stage, hind limb length, 
snout-vent length and wet body weight on days 7 and 21 
and thyroid gland histology on day 21. The most prominent 
morphological staging landmark is hind limb morphology, 
which is positively associated with agonistic effects57,58.
Regarding the histopathology of the thyroid gland, the 
guidelines mention core criteria and additional qualitative 
criteria along with grading, as shown in Table 3.
For a more detailed understanding, information is 
available in “Amphibian Metamorphosis Assay: Part 1 – 
Technical guidance for morphologic sampling and histolog-
Table 1.  Protocol of the AMA
Test animal Xenopus laevis larvae
Initial larval stage Nieuwkoop and Faber stage 51
Exposure period 21 days
Larvae selection criteria Developmental stage and total length (optional)
Test concentrations Minimum of 3 concentrations spanning approximately one order of magnitude
Exposure regime Flow-through (preferred) and/or static-renewal
Test system flow rate 25 mL/min
Larval density 20 larvae/test vessel (5 larvae/L)
Test solution/test vessel 4–10 L (10–15 cm minimum water) / glass or stainless steel test vessel  
(e.g., 22.5 cm × 14 cm × 16.5 cm)
Replication 4 replicate test vessels / test concentration and control
Acceptable mortality rate in controls ≤ 10% per replicate test vessel
Water temperature 22 ± 1°C
Lighting 12 h Light: 12 h dark, 600 to 2000 lux
Thyroid fixation Davidson’s fixative
pH 6.5–8.5
Dissolved oxygen concentration > 3.5 mg/L (> 40% air saturation)
Table 2.  Observation Time Points for Primary Endpoints in the AMA
Apical endpoints Observation time points
Mortality Daily
Developmental stage Day 7 and 21, comply with N&F Stage
Hind limb length Day 7 and 21
Snout-vent length Day 7 and 21
Wet body weight Day 7 and 21
Thyroid gland histology Day 21, comply with guidance for histopathology
Table 3.  Diagnostic Criteria, Severity and Grading for Histopathology 
in AMA
Core criteria (severity graded)
• Thyroid gland hypertrophy/atrophy
• Follicular cell hypertrophy
• Follicular cell hyperplasia
Additional criteria (severity graded and/or qualitatively described)
• Follicular lumen area: reduced or increased
• Colloid quality: homogeneous, heterogeneous, lacy or granular
• Follicular cell height/shape: squamous, cuboidal, low/high 
columnar
Grading (For multifocal or diffusely-distributed alteration, the 
percentage of tissue area involved should be considered.)
• Grade 0 (not remarkable to minimal, less than 20%)
• Grade 1 (mild, 30–50%)
• Grade 2 (moderate, 60–80%)
• Grade 3 (severe, over 80%)Thyroid Hormone and Amphibian Metamorphosis Assay 6
ical preparation” and “Amphibian Metamorphosis Assay: 
Part 2 – Approach to reading studies, diagnostic criteria, 
severity grading and atlas”61,62. In addition, in support of the 
OECD AMA test guideline, a document was developed that 
provides a standardized approach for evaluating the histol-
ogy/histopathology of thyroid glands63, including an atlas 
of the normal architecture of amphibian thyroid glands over 
the course of metamorphosis.
One article regarding an examination conducted in 
compliance with these guidelines supported the use of the 
AMA as a Tier 1 endocrine screen for detection of potential 
thyroid pathway activity, but the lack of a true negative re-
sponse (no effect) during the validation process prevents full 
evaluation of this assay’s specificity at this time64.
The Importance and Difficulty of Histopatho-
logical Examination
Each of the mechanisms mentioned above can alter 
concentrations of circulating THs. Under conditions of TH 
decrease, a result of feedback of circulating THs on the HPT 
axis, there is increased secretion of TSH from the pituitary 
gland. Such excessive stimulation would be expected to re-
sult in an increased thyroid gland size, increased degree of 
follicular cell hyperplasia and/or increased degree of follic-
ular cell hypertrophy, as is well documented for the rodent 
thyroid gland65. O’Connor et al. stated that histopathological 
change of the thyroid gland is the most valuable information 
regarding thyroid toxicants66, and histological examination 
of the amphibian thyroid gland has been shown to be a very 
sensitive approach in several studies. Figure 4 illustrates 
thyroid glands exposed to T4 or PTU along with controls. 
Although the developmental stage and hind limb length are 
important endpoints of antithyroid activity, developmental 
delay cannot, by itself, be considered a diagnostic indicator 
of antithyroidal activity. Therefore, conducting histopatho-
logical analyses of the thyroid glands is an essential require-
ment.
A series of validation assays verified that thyroid his-
topathology is sensitive and reliable for antithyroidal activ-
ity resulting from either inhibition of thyroidal iodide up-
take or iodide organification. On the other hand, according 
to the phase 1 validation study, histopathological analyses 
of thyroid glands of T4-treated tadpoles were less consis-
tent between the laboratories and more difficult to inter-
pret compared with the effects seen in the PTU studies57. 
Furthermore, the phase 2 validation report mentioned that 
while thyroid histopathology was sensitive for antithyroidal 
activities, weak agonistic activity could not be reliably de-
tected58.
Thyroid histopathology is complex. Depletion of col-
loid stores and increases in epithelial cell height are known 
to occur at climax stages during normal development when 
TSH synthesis and release by the pituitary and T4 synthesis 
and secretion by the thyroid gland reach maximum levels63. 
Therefore, there may be difficulty in distinguishing whether 
histological changes occur in response to alterations of the 
HPT axis or alternatively merely reflect advanced stages 
in tadpoles. In fact, the guidelines insist that the most ap-
propriate sampling approach for histological analyses is to 
use stage-matched individuals whenever possible. In order 
to select stage-matched individuals, all larvae should first 
be staged prior to selection and subsequent processing for 
data collection and preservation. This is necessary because 
normal divergence in development will result in differential 
stage distributions within each replicate tank.
There is one example showing that amphibian thyroid 
histopathology is extremely complex53, and when misin-
terpretation occurs, it leads to the opposite conclusion. In 
a controversial issue regarding the effect of triclosan, Fort 
Fig. 4.  Thyroid glands after exposure for 21 days beginning at Stage 51. Left: Control. Middle: PTU 25 ppm. Right: 
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and Pawlowski reported in regard to the histopathological 
changes that an increase in the occurrence of minimal thy-
roid gland hypertrophy was not accompanied by follicular 
hypertrophy or hyperplasia54. The lack of follicular hyper-
trophy or hyperplasia was suggested to be the result of both 
the minimal nature of the response and the increased body 
size of the treated specimens.
Conclusion
Because disruption of the thyroid axis has been identi-
fied as an important consideration for regulation of chemi-
cals, the OECD and EPA have established guidelines that 
make for use of larval African clawed frogs (X. laevis) and 
frog metamorphosis for screening and testing of potential 
endocrine disrupters. In the test guidelines, thyroid gland 
histology is one of the primary endpoints, along with mor-
tality, developmental stage, hind limb length, snout-vent 
length and wet body weight. A series of validation studies 
and many reports have revealed that the histopathology of 
the thyroid gland is very sensitive and reliable for detection 
of antithyroidal activity but, on the other hand, is less use-
ful for weak agonistic effects. Since the morphology of the 
amphibian thyroid gland changes continuously throughout 
metamorphosis with the fluctuation in TH levels, the guide-
lines stress the need for well experienced toxicologic pa-
thologists who are familiar with normal X. laevis thyroid 
histology, thyroid gland physiology and general responses 
of the thyroid gland to agonists or antagonists.
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